Medpace Holdings Inc
MEDP
Get informed when a big investor buys or sells
+ FollowMarket Cap$16.73B
Close$
$582.20
2.9% downside
Current Fair Value
2.9% downsideOvervalued by 2.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $16.73 Billion |
|---|---|
| Enterprise Value | $17.25 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $15.64 |
| Beta | 1.15 |
| Outstanding Shares | 28,308,000 |
Return
| Return on Equity | 113.29% |
|---|---|
| Return on Assets | 23.89% |
| Return on Invested Capital | 93.59% |
Valuation & Multiples
| P/E Ratio | 34.47 |
|---|---|
| PEG | 100.04 |
| Price to Sales | 6.12 |
| Price to Book Ratio | 39.96 |
| Enterprise Value to Revenue | 6.2 |
| Enterprise Value to EBIT | 29.65 |
| Enterprise Value to Net Income | 35 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 2.36 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 22, 2026
EPS Estimate
$3.98
Average shareholder expectationRevenue Estimate
$689.51 M
Average shareholder expectationNext Earnings Call
Expected Date
October 21, 2026
EPS Estimate
$4.42
Average shareholder expectationRevenue Estimate
$714.44 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 5.1076▲ 325.07% |
|---|---|
| Total Calls | 34,400▲ 44.51% |
| Total Puts | 175,700▲ 297.51% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 88.55%▲ 3.81% |
|---|---|
| Total Invested | $13.18B▲ 14.10% |
| Investors Holding | 713▼ 30.00% |
ESG Score
No data
About Medpace Holdings Inc
CEO: August Troendle